JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB265897

Human UBXN4 (Erasin) knockout HeLa cell line

Be the first to review this product! Submit a review

|

(0 Publication)

UBXN4 KO cell line available to order. KO validated by. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, Homozygous: 35 bp deletion in exon 1. To order both knockout and wild-type control cells: select 2 x 1000000Cells/vial. To order only knockout cells: select 1000000Cells/vial.

View Alternative Names

Erasin, FLJ23318, KIAA0242, KIAA2042, UBX domain containing 1, UBX domain containing 2, UBX domain containing protein 2, UBXD 2, UBXDC 1

1 Images
Sanger Sequencing - Human UBXN4 (Erasin) knockout HeLa cell line (AB265897)
  • Sanger seq

Unknown

Sanger Sequencing - Human UBXN4 (Erasin) knockout HeLa cell line (AB265897)

Homozygous : 35 bp deletion in exon 1.

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: 35 bp deletion in exon 1

Disease

Adenocarcinoma

Product details

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab265897-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265897 Human UBXN4 (Erasin) knockout HeLa cell line", "number":"AB265897-CMP01" }, { "size":"1 x 1000000 Cells/vial", "name":"ab255928 Human wild-type HeLa cell line", "number":"AB265897-CMP02" } ] }, "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab265897-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265897 Human UBXN4 (Erasin) knockout HeLa cell line", "number":"AB265897-CMP01" }, { "size":"1 x 1000000 Cells/vial", "name":"ab255928 Human wild-type HeLa cell line", "number":"AB265897-CMP02" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265897-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265897 Human UBXN4 (Erasin) knockout HeLa cell line", "number":"AB265897-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265897-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265897 Human UBXN4 (Erasin) knockout HeLa cell line", "number":"AB265897-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
UBXN4
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Zygosity
Homozygous
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Erasin also known as X15H8 protein is a cellular protein with a mass of approximately 54 kDa. It functions as a molecular chaperone by helping in the folding and assembly of nascent polypeptides into functional proteins. Erasin is expressed mostly in liver and kidney tissues but can also be found in smaller amounts in other organs. This expression pattern supports its involvement in maintaining protein homeostasis and cellular proteostasis mechanisms in metabolically active tissues.
Biological function summary

The roles of Erasin extend beyond its chaperone activities. It is a component of a larger proteostasis network interacting with other cellular machineries to regulate degradation processes. Erasin helps in stabilizing misfolded proteins and prevents aggregation which could be harmful to the cell. Its presence in the endoplasmic reticulum signifies its function in protein quality control and stress response especially under conditions that challenge cellular homeostasis.

Pathways

Erasin actively participates in the unfolded protein response (UPR) and ER-associated degradation (ERAD) pathways. These pathways are important for eliminating defective proteins and maintaining cellular equilibrium. Erasin interacts closely with Bip and Calnexin both of which are key players in the ER stress response. By aiding these networks Erasin contributes to cellular health by ensuring that proteins achieve and maintain their correct structures.

Erasin engages in conditions related to protein misfolding and aggregation. Alzheimer's disease and cystic fibrosis are two such disorders where proteostasis is disrupted. In Alzheimer's disease the accumulation of misfolded amyloid-beta peptides links back to Erasin's role in protein folding and clearance. Similarly Erasin's interaction with DeltaF508-CFTR highlights its involvement in cystic fibrosis where proper folding of the CFTR protein is impaired. These associations highlight the pivotal role of Erasin in conditions that challenge cellular protein management.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com